azacitidine has been researched along with Carcinoma, Ductal, Breast in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasiadis, PZ; Andorfer, CA; Borges, S; Döppler, H; Geiger, XJ; Perez, EA; Storz, P; Sun, Z; Thompson, E | 1 |
| Broggini, M; Cavalli, IJ; Chilà, R; Damia, G; de Lima, RS; de Oliveira, SF; Ganzinelli, M; Generali, D; Maciel, ME; Ribeiro, EM; Serino, L; Urban, Cde A | 1 |
| Kong, X; Liu, A; Liu, J; Liu, Y; Su, Y; Sun, P; Wang, X; You, D; Yuan, L; Zhang, D; Zhang, X | 1 |
| Chen, L; Fu, DY; Huang, W; Shao, ZM; Shen, ZZ; Wang, BL; Wang, ZM; Yang, WT | 1 |
| Asa, SL; Ezzat, S; Zheng, L; Zhu, X | 1 |
| Baraty, C; Bianco, C; Castro, NP; Gonzales, M; Held, N; Karasawa, H; Rangel, MC; Rollman, K; Salomon, DS; Strizzi, L | 1 |
| Bell, SM; Carder, PJ; Hanby, AM; Horgan, K; Lane, S; Lansdown, MR; Markham, AF; Munot, K; Parkes, AT; Skliris, GP; Speirs, V | 1 |
| Christgen, M; Hasemeier, B; Kreipe, H; Länger, F; Lehmann, U; Müller, M; Römermann, D | 1 |
| Clare, SE; Clark, G; Elkahloun, AG; Hartsough, MT; Mair, M; Osborne, CK; Sgroi, D; Steeg, PS | 1 |
9 other study(ies) available for azacitidine and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Cell Movement; Cell Proliferation; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Promoter Regions, Genetic; Protein Kinase C; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Array Analysis; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Azacitidine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Estrogen Receptor alpha; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Methotrexate; Organ Specificity; Promoter Regions, Genetic; Purine-Nucleoside Phosphorylase; Receptor, ErbB-2; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms | 2016 |
Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.
Topics: Adult; Azacitidine; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Glucosyltransferases; Humans; MCF-7 Cells; Neoplasm Invasiveness; Promoter Regions, Genetic | 2016 |
Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Biomarkers, Tumor; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Receptor, EphA5; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger | 2010 |
Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Animals; Azacitidine; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Germ-Line Mutation; Humans; Loss of Heterozygosity; Mice; Mice, SCID; Middle Aged; Polymorphism, Single Nucleotide; Receptor, Fibroblast Growth Factor, Type 4; Selection, Genetic; Xenograft Model Antitumor Assays | 2010 |
Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.
Topics: Azacitidine; Binding Sites; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Embryonal; Cell Movement; Decitabine; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Embryonal Carcinoma Stem Cells; Female; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Genes, Reporter; GPI-Linked Proteins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Luciferases; MCF-7 Cells; Neoplasm Invasiveness; Neoplasm Proteins; Nuclear Receptor Subfamily 6, Group A, Member 1; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; RNA Interference; RNA, Messenger; Time Factors; Tissue Array Analysis; Transcription, Genetic; Transfection; Tretinoin; Valproic Acid | 2013 |
Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model.
Topics: Age Factors; Azacitidine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chi-Square Distribution; Decitabine; DNA Methylation; DNA Modification Methylases; Estrogen Receptor beta; Female; Gene Silencing; Humans; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Recurrence, Local; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Uterine Cervical Dysplasia | 2003 |
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
Topics: Azacitidine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; MicroRNAs; RNA, Neoplasm; Tumor Cells, Cultured | 2008 |
Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Movement; CpG Islands; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Monomeric GTP-Binding Proteins; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Promoter Regions, Genetic; Transcription Factors; Transfection; Tumor Cells, Cultured | 2001 |